This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

AIG's Top 10 Losses: From Bad to Worse

No. 5: $3.6 billion in goodwill impairments. That's the same amount that: a.) Merrill Lynch paid in bonuses the night before Bank of America (BAC - Get Report) took control; and b.) the increase that veterans groups have called for in health care.

No. 4: $4.4 billion as a result of a credit valuation adjustment. That's the same amount that: a.) Vietnam has invested in overseas development; and b.) Medicare is owed in overpayments by insurance companies.

No. 3: $6.9 billion paid in interest and amortization on credit lines provided by the Fed. That's the same amount that: Fannie Mae and Freddie Mac reportedly owned in foreclosed homes a year ago; and b.) the total sales of the world's largest diamond corporation, De Beers Group, in 2008.

No. 2: $13 billion in other-than-temporary impairment charges (losses on the value of investment assets). That's the same amount as: Nigeria's bilateral trade with India in 2008; and b.) bailout funding the government provided to automakers in December.

No. 1: $21 billion in lost tax benefits. That's the same amount as: a.) sales that the entire video gaming industry booked in 2008; b.) the estimated value of the Bollywood film industry; and c.) of course, the commercial paper credit line that AIG received last year when $1 billion still meant something.

Oh, there was another $2.3 billion in the "other" category, bringing the total to $64.1 billion.

This is how a $62 billion loss can appear reasonable.


Do you support the government's plan to give even more financial aid to AIG?

Yes. The company must be supported to keep the financial system from collapsing.
Yes. But the government needs to address the company's problems more quickly.
No. The company needs to sort out its issues without more funds.
No. Taxpayers have had enough of this. If it fails, it fails.

Gavin Magor joined TheStreet.com Ratings in 2008, and is the senior analyst responsible for assigning financial strength ratings to health insurers and supporting other health care-related consumer products, including Medicare supplement insurance, long-term care insurance and elder care information. He conducts industry analysis in these areas. He has more than 20 years' international experience in credit risk management, commercial lending and analysis, working in the U.K., Sweden, Mexico, Brazil and the U.S. He holds a master's degree in business administration from The Open University in the U.K.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ABT $47.01 0.00%
AXP $80.63 0.00%
AIG $55.38 0.00%
BAC $15.84 0.00%
FITB $19.28 0.00%

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs